According to Quotient's latest financial reports the company's current revenue (TTM) is $37.41 M. In 2021 the company made a revenue of $38.36 M a decrease over the years 2020 revenue that were of $42.44 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $37.41 M | -2.49% |
2021 | $38.36 M | -9.6% |
2020 | $42.44 M | 31.65% |
2019 | $32.23 M | 19.44% |
2018 | $26.99 M | 11.89% |
2017 | $24.12 M | 10.92% |
2016 | $21.74 M | 25.13% |
2015 | $17.37 M | -9.3% |
2014 | $19.16 M | 3.38% |
2013 | $18.53 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Atossa Therapeutics ATOS | N/A | N/A | ๐บ๐ธ USA |
Chembio Diagnostics CEMI | $48.33 M | 29.22% | ๐บ๐ธ USA |
Eterna Therapeutics ERNA | $0.06 M | -99.82% | ๐บ๐ธ USA |